{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:58:38Z","timestamp":1791050318733,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.jaci.2009.06.049","type":"journal-article","created":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T06:33:47Z","timestamp":1255070027000},"page":"160-169.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Murine atopic dermatitis responds to peroxisome proliferator-activated receptors \u03b1 and \u03b2\/\u03b4 (but not \u03b3) and liver X receptor activators"],"prefix":"10.1016","volume":"125","author":[{"given":"Yutaka","family":"Hatano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Qiang","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Crumrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora M.","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Feingold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter M.","family":"Holleran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2009.06.049_bib1","first-page":"119","article-title":"Epidermal pathogenesis of inflammatory dermatoses","volume":"10","author":"Elias","year":"1999","journal-title":"Am J Contact Dermat"},{"key":"10.1016\/j.jaci.2009.06.049_bib2","first-page":"1079","article-title":"Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications","volume":"137","author":"Elias","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0889-8561(05)70318-0","article-title":"Relationship of the epidermal permeability barrier to irritant contact dermatitis","volume":"17","author":"Elias","year":"1997","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2009.06.049_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0536.1999.tb06125.x","article-title":"Hypothesis: from epidermal barrier dysfunction to atopic disorders","volume":"41","author":"Taieb","year":"1999","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaci.2009.06.049_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2340\/0001555575429433","article-title":"Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin","volume":"75","author":"Seidenari","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2009.06.049_bib6","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archderm.139.11.1417","article-title":"The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease","volume":"139","author":"Sugarman","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0738-081X(02)00370-X","article-title":"Skin lipids and epidermal differentiation in atopic dermatitis","volume":"21","author":"Proksch","year":"2003","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2009.06.049_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaci.2006.05.004","article-title":"Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations","volume":"118","author":"Weidinger","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.06.049_bib10","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/sj.jid.5700365","article-title":"Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis","volume":"126","author":"Irvine","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2006.04.042","article-title":"New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions","volume":"118","author":"Cork","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.06.049_bib12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2009.06.049_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00128071-200708040-00001","article-title":"Cancer concerns with topical immunomodulators in atopic dermatitis: overview of data and recommendations to clinicians","volume":"8","author":"Patel","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1600-0625.2007.00555.x","article-title":"Calcineurin inhibitors and rapamycin: cancer protection or promotion?","volume":"16","author":"Weischer","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1194\/jlr.R800001-JLR200","article-title":"Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology","volume":"49","author":"Schmuth","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jaci.2009.06.049_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.0022-202x.2001.01626.x","article-title":"Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models","volume":"118","author":"Sheu","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1523-1747.2003.12033.x","article-title":"Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production","volume":"120","author":"Fowler","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1523-1747.2000.00076.x","article-title":"Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis","volume":"115","author":"Komuves","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.jid.5701011","article-title":"Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges","volume":"128","author":"Man","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.0022-202X.2005.23799.x","article-title":"Is endogenous glycerol a determinant of stratum corneum hydration in humans?","volume":"125","author":"Choi","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.0022-202X.2005.23836.x","article-title":"Extracellular pH Controls NHE1 expression in epidermis and keratinocytes: implications for barrier repair","volume":"125","author":"Hachem","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0625.2006.00402.x","article-title":"Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model","volume":"15","author":"Demerjian","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/1523-1747.ep12461361","article-title":"Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and x-ray diffraction","volume":"96","author":"Hou","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.0022-202X.2005.23838.x","article-title":"Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity","volume":"125","author":"Hachem","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0029(19970815)38:4<361::AID-JEMT4>3.0.CO;2-M","article-title":"Epidermal barrier in disorders of the skin","volume":"38","author":"Fartasch","year":"1997","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.jaci.2009.06.049_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/mjd.2002.124617","article-title":"Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity","volume":"47","author":"Chamlin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/1523-1747.ep12335839","article-title":"Decreased level of prosaposin in atopic skin","volume":"109","author":"Cui","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1523-1747.1998.00370.x","article-title":"Localization of sphingomyelinase in lesional skin of atopic dermatitis patients","volume":"111","author":"Kusuda","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"suppl","key":"10.1016\/j.jaci.2009.06.049_bib29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/bj3500747","article-title":"The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide","volume":"350","author":"Higuchi","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.jaci.2009.06.049_bib30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1523-1747.2000.00072.x","article-title":"High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis","volume":"115","author":"Hara","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib31","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1038\/sj.jid.5700351","article-title":"Serine protease signaling of epidermal permeability barrier homeostasis","volume":"126","author":"Hachem","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.0022-202X.2004.23235.x","article-title":"Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation","volume":"123","author":"Mao-Qiang","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib33","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jaci.2008.01.022","article-title":"Basis for the barrier abnormality in atopic dermatitis: \u201coutside-inside-outside\u201d pathogenic mechanisms","volume":"121","author":"Elias","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.06.049_bib34","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaci.2007.12.1165","article-title":"Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis","volume":"121","author":"Staumont-Salle","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.06.049_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/1523-1747.ep12363729","article-title":"Inhibition of cholesterol and sphingolipid synthesis causes paradoxical effects on permeability barrier homeostasis","volume":"101","author":"Mao-Qiang","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archdermatol.2007.22","article-title":"A retrospective case series review of the peroxisome proliferator-activated receptor ligand rosiglitazone in the treatment of atopic dermatitis","volume":"144","author":"Behshad","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib37","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jaci.2008.01.022","article-title":"Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms","volume":"121","author":"Elias","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.06.049_bib38","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/jid.2008.88","article-title":"Outside-to-inside' (and now back to \u201coutside\u201d) pathogenic mechanisms in atopic dermatitis","volume":"128","author":"Elias","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib39","doi-asserted-by":"crossref","first-page":"14795","DOI":"10.1073\/pnas.0507385102","article-title":"Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin","volume":"102","author":"Li","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2009.06.049_bib40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/1523-1747.ep12413597","article-title":"Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption","volume":"103","author":"Wood","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib41","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/jid.2008.444","article-title":"Maintenance of a acidic stratum corneum prevents emergence of murine atopic dermatitis","volume":"129","author":"Hatano","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.06.049_bib42","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1194\/jlr.R800002-JLR200","article-title":"Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism","volume":"49","author":"Elias","year":"2008","journal-title":"J Lipid Res"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674909010938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674909010938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:22:12Z","timestamp":1758788532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674909010938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0091674909010938"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2009.06.049","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Murine atopic dermatitis responds to peroxisome proliferator-activated receptors \u03b1 and \u03b2\/\u03b4 (but not \u03b3) and liver X receptor activators","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2009.06.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}